The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Molecular pathology of schizophrenia: more than one disease process?
Open accessAbstract
We have developed a generally applicable method based on CRISPR/Cas9-targeted ultra-long read sequencing (CTLR-Seq) to completely and haplotype-specifically resolve, at base-pair resolution, large, complex, and highly repetitive genomic regions that had been previously impenetrable to next-generation sequencing analysis such as large segmental duplication (SegDup) regions and their associated genome rearrangements that stretch hundreds of kilobases. Our method combines in vitro Cas9-mediated cutting of the genome and pulse-field gel electrophoresis to haplotype-specifically isolate intact large (200-550 kb) target regions that encompass previously unresolvable genomic sequences. These target fragments are then sequenced (amplification-free) to produce ultra-long reads at up to 40x on-target coverage using Oxford nanopore technology, allowing for the complete assembly of the complex genomic regions of interest at single base-pair resolution. We applied CTLR-Seq to resolve the exact sequence of SegDup rearrangements that constitute the boundary regions of the 22q11.2 deletion CNV and of the 16p11.2 deletion and duplication CNVs. These CNVs are among the strongest known risk factors for schizophrenia and autism. We then perform de novo assembly to resolve, for the first time, at single base-pair resolution, the sequence rearrangements of the 22q11.2 and 16p11.2 CNVs, mapping out exactly the genes and non-coding regions that are affected by the CNV for different carriers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Carlsson, A., & Lindqvist, M. (1963) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1963.tb01730.x · Cited by 2,148
Dalgleish, T. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1432 · Cited by 1,849
Antipsychotic drug doses and neuroleptic/dopamine receptors
SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622
Stereotyped activities produced by amphetamine in several animal species and man
Randrup, A., & Munkvad, I. (1967) · Psychopharmacologia · doi:10.1007/bf00404607 · Cited by 613
A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS
Woolley, D. W., & Shaw, E. (1954) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.40.4.228 · Cited by 602
Lateral Cerebral Ventricular Enlargement in Chronic Schizophrenia
Weinberger, D. R. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780070013001 · Cited by 570
INCREASED DOPAMINE-RECEPTOR SENSITIVITY IN SCHIZOPHRENIA
Owen, F., Crow, T. J., Poulter, M., Cross, A. J., Longden, A., & Riley, G. J. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91740-3 · Cited by 518
Self-citationStein, L., & Wise, C. D. (1971) · Science · doi:10.1126/science.171.3975.1032 · Cited by 477
MECHANISM OF THE ANTIPSYCHOTIC EFFECT IN THE TREATMENT OF ACUTE SCHIZOPHRENIA
Johnstone, E., Frith, C. D., Crow, T. J., Carney, M. W. P., & Price, J. S. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90193-9 · Cited by 458
Self-citation
Cited by
Items 101–131 of 131
Messinger, J. W., Trémeau, F., Antonius, D., Mendelsohn, E., Prudent, V., Stanford, A. D., & Malaspina, D. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.09.002 · Cited by 271
Anhedonia in schizophrenia and major depression: state or trait
Pelizza, L., & Ferrari, A. (2009) · Annals of General Psychiatry · doi:10.1186/1744-859x-8-22 · Cited by 271
The Positive-Negative Distinction in Schizophrenia: Review of Natural History Validators
McGlashan, T. H. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820010063008 · Cited by 270
Subtyping schizophrenia: implications for genetic research
Jablensky, A. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001857 · Cited by 268
Negative and Positive Symptoms in Schizophrenia and Depression: A Followup
Pogue-Geile, M. F., & Harrow, M. (1984) · Schizophrenia Bulletin · doi:10.1093/schbul/10.3.371 · Cited by 261
THE LEFT MEDIAL TEMPORAL REGION AND SCHIZOPHRENIA: A PET STUDY
FRISTON, K. J., LIDDLE, P. F., FRITH, C. D., HIRSCH, S. R., & FRACKOWIAK, R. S. J. (1992) · Brain · doi:10.1093/brain/115.2.367 · Cited by 259
Cognition in schizophrenia: Past, present, and future
Green, M. F., & Harvey, P. D. (2014) · Schizophrenia Research: Cognition · doi:10.1016/j.scog.2014.02.001 · Cited by 258
Semantic priming in thought disordered schizophrenic patients
Manschreck, T. C., Maher, B. A., Milavetz, J. J., Ames, D., Weisstein, C. C., & Schneyer, M. L. (1988) · Schizophrenia Research · doi:10.1016/0920-9964(88)90041-2 · Cited by 257
Dexamethasone Suppression Test in Depression and other Psychiatric Illness
Coppen, A., Abou-Saleh, M., Milln, P., Metcalfe, M., Harwood, J., & Bailey, J. (1983) · British Journal of Psychiatry · doi:10.1192/bjp.142.5.498 · Cited by 256
Dimensions of Outcome with Clozapine
Meltzer, H. Y. (1992) · British Journal of Psychiatry · doi:10.1192/s000712500029692x · Cited by 252
Emrich, H. M., Leweke, F. M., & Schneider, U. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00426-1 · Cited by 226
Negative symptoms of schizophrenia: a problem that will not go away
Stahl, S. M., & Buckley, P. F. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00947.x · Cited by 195
Gender differences in the clinical expression of schizophrenia
Shtasel, D. L., Gur, R. E., Gallacher, F., Heimberg, C., & Gur, R. C. (1992) · Schizophrenia Research · doi:10.1016/0920-9964(92)90016-x · Cited by 176
Effects of the acute administration of caffeine in patients with schizophrenia
Lucas, P. B., Pickar, D., Kelsoe, J., Rapaport, M., Pato, C., & Hommer, D. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90429-6 · Cited by 125
Negative symptoms in first episode non‐affective psychosis
Malla, A. K., Takhar, J. J., Norman, R. M. G., Manchanda, R., Cortese, L., Haricharan, R., Verdi, M., & Ahmed, R. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2002.02139.x · Cited by 118
Psychiatric symptoms of noradrenergic dysfunction: A pathophysiological view
Yamamoto, K., Shinba, T., & Yoshii, M. (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12126 · Cited by 88
Depressive and negative symptoms in schizophrenia: different effects on clinical features
Rocca, P., Bellino, S., Calvarese, P., Marchiaro, L., Patria, L., Rasetti, R., & Bogetto, F. (2005) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2004.09.001 · Cited by 76
Susceptibility to backward masking in schizophrenic patients with positive or negative symptoms
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.10.1273 · Cited by 75
Patterns of positive and negative symptoms in first episode schizophrenia
Vázquez-Barquero, J. L., Lastra, I., Nuñez, M. J. C., Castanedo, S. H., & Dunn, G. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.168.6.693 · Cited by 73
Competing Definitions of Schizophrenia: What Can Be Learned From Polydiagnostic Studies?
Jansson, L. B., & Parnas, J. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl065 · Cited by 73
Affective modulation of the startle reflex in schizophrenic patients
Schlenker, R., Cohen, R., & Hopmann, G. (1995) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02191873 · Cited by 68
“" (pp 280-281) Within the framework of the concept of negative symptoms in schizophrenia, disordered affect has recently attracted new interest (Crow 1980; Andreasen 1982).”
BackgroundElectrodermal predictors of functional outcome and negative symptoms in schizophrenia
Schell, A. M., Dawson, M. E., Rissling, A., Ventura, J., Subotnik, K. L., Gitlin, M. J., & Nuechterlein, K. H. (2005) · Psychophysiology · doi:10.1111/j.1469-8986.2005.00300.x · Cited by 68
Curtis, C. E., Lebow, B., Lake, D. S., Katsanis, J., & Iacono, W. G. (1999) · Psychophysiology · doi:10.1017/s0048577299980757 · Cited by 66
Dimensional vs. categorical diagnosis in psychosis
Rosenman, S., Korten, A., Medway, J., & Evans, M. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2003.00059.x · Cited by 64
Serretti, A., Macciardi, F. M., & Smeraldi, E. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19960726)67:4<393::aid-ajmg13>3.0.co;2-e · Cited by 67
Pituitary volume, stress reactivity and genetic risk for psychotic disorder
Habets, P., Collip, D., Myin-Germeys, I., Gronenschild, E., van Bronswijk, S., Hofman, P., Lataster, T., Lardinois, M., Nicolson, N. A., van Os, J., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291711002728 · Cited by 46
Revisiting the Diagnosis of Schizophrenia: Where have we been and Where are We Going?
Keller, W. R., Fischer, B. A., & Carpenter Jr., W. T. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00229.x · Cited by 46
Is our concept of schizophrenia influenced by Berkson's bias?
Maric, N., Myin-Germeys, I., Delespaul, P., de Graaf, R., Vollebergh, W., & Van Os, J. (2004) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-004-0803-z · Cited by 45
“Dimensions of negative symptoms,positive symptoms and depression were reported in patients with not only psychotic disorders (Strauss et al. 1974; Crow 1980; Andreasen and Olsen 1982; Bilder et al. 1985; Liddle et al. 1989; Cuesta and Peralta 1995), including schizoaffective and affective psychosis…”
BackgroundLuminance flicker sensitivity in positive- and negative-symptom schizophrenia
Slaghuis, W. L., & Bishop, A. M. (2001) · Experimental Brain Research · doi:10.1007/s002210100683 · Cited by 41
Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation
Schultz, S. K., Miller, D. D., Arndt, S., Ziebell, S., Gupta, S., & Andreasen, N. C. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00082-8 · Cited by 29
Health states for schizophrenia and bipolar disorder within the Global Burden of Disease 2010 Study
Ferrari, A. J., Saha, S., McGrath, J. J., Norman, R., Baxter, A. J., Vos, T., & Whiteford, H. A. (2012) · Population Health Metrics · doi:10.1186/1478-7954-10-16 · Cited by 1
“Positive symptoms can be followed by the development of negative symptoms or they can both occur simultaneously with one set of symptoms being more noticeable than the other [14,19], and this can be affected by treatment.”
Background
Metadata
- Authors
- Crow, T. J.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1980-01-12
- Volume
- 280
- Issue
- 6207
- Pages
- 66-68
- ISSN
- 0007-1447 (ISSN-L)
- 1468-5833
- OpenAlex
- W1970814820
- Cited by
- 1,856
- References
- 37
- FWCI
- 26.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.